Gena Wang, an analyst from Barclays, maintained the Hold rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided updates on multiple kidney diseases in its pipeline including IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Learn more about it. Whether you’re ready or not, the holidays will be here in a flash, and retailers are starting to market their 2024 Advent calendars. These calendars help you count down the ...

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts ...

Spider-Man fans will love this Advent calendar, which includes 5 mini-figures: Spider-Man, Green Goblin, Miles Morales, Ghost-Spider and Venom. Peter Parker’s desk and a cozy fireplace (complete ...

We’ve come a long way from the humble chocolate Advent calendar. Now, you can buy an Advent calendar filled with just about anything you can think of, from skin-care products to dog treats to ...

VRTX's core cystic fibrosis portfolio remains its top/ bottom-line driver, with elongated patent expiry for TRIKAFTA/KAFTRIO through 2037. Even so, the management is not resting on its laurels ...

More than three-quarters (77%) of health care providers surveyed stated that treating moderate-to-severe acute pain with ...

With an FDA decision looming over its first foray into the acute pain space, Vertex Pharmaceuticals has commissioned a pair of surveys to take stock of that space. The resulting report ...